We individualize based on labs and symptoms
Now, research has shown that GLP-1 in higher dosages signals a feeling of fullness to cause significant weight loss and reduce the risk of cancer, diabetes, and heart disease in overweight individuals
Experts highlighted the need for healthcare education on recognizing B12 deficiency symptoms and suggested targeted prophylactic supplementation for high-risk groups
Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice
In this article, well break down: What each drug does Why stacking them could accelerate results How they compare to Ozempic vs Retatrutide Whats next for this next-generation treatment Key Takeaways Retatrutide is a triple-hormone agonist (GLP-1/GIP/glucagon) showing record-breaking fat-loss results in clinical trials
The difference between semaglutide and tirzepatide, besides the fact that one is a single-hormone and the other is a dual-hormone agonist, is how effective they are, Anekwe said